Avant Technologies and Ainnova in Talks for Preventative Health Innovation

Avant Technologies Inc. and Ainnova Tech, Inc. announced discussions with an international healthcare innovation company. Their aim is to license or acquire technology for early disease detection, potentially transforming preventive health reporting. This initiative could enable future disease detection without needing all patient data.

The companies aim to enhance their AI-driven Vision AI technology platform, focusing on early disease detection. Vinicio Vargas, Ainnova's CEO, emphasized their goal of accessible and cost-effective preventive check-ups to mitigate risk factors.

Currently, Avant and Ainnova view the retina as a vital health sign, integrating lab results and basic data for comprehensive reports. They have secured exclusive licenses for four algorithms and are pursuing new technological acquisitions.